Ovid Therapeutics Reports Business Updates and First Quarter 2026 Financial Results

Go back to Ovid Therapeutics Reports Business Updates and First Quarter 2026 Financial Results
(NASDAQ: OVID) Delayed: 2.25 -0.02 (0.88%)
Previous Close $2.27    52 Week High
Open $2.32    52 Week Low
Day High $2.37    P/E N/A 
Day Low $2.22    EPS
Volume 1,948,881